| scholarly article | Q13442814 |
| P50 | author | Bauke Ylstra | Q30429855 |
| Reiner Siebert | Q78771973 | ||
| José I Martín-Subero | Q39062643 | ||
| Lars O. Baumbusch | Q64210488 | ||
| P2093 | author name string | Klaus Pantel | |
| Benjamin Otto | |||
| Udo Schumacher | |||
| Wolfgang Deppert | |||
| Florian Wegwitz | |||
| Thomas Streichert | |||
| Christina Heinlein | |||
| Genrich V Tolstonog | |||
| Christoph Wagener | |||
| Peter Nollau | |||
| Katharina Gruner | |||
| P2860 | cites work | Galaxy: a comprehensive approach for supporting accessible, reproducible, and transparent computational research in the life sciences | Q21092859 |
| COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer | Q24608391 | ||
| Mutation of the c-Cbl TKB domain binding site on the Met receptor tyrosine kinase converts it into a transforming protein | Q28210330 | ||
| Invasive growth: a MET-driven genetic programme for cancer and stem cells | Q28253680 | ||
| The Pea3 Ets transcription factor regulates differentiation of multipotent progenitor cells during mammary gland development | Q28588489 | ||
| PEA3 transcription factors are expressed in tissues undergoing branching morphogenesis and promote formation of duct-like structures by mammary epithelial cells in vitro | Q28589944 | ||
| Identification of cancer genes using a statistical framework for multiexperiment analysis of nondiscretized array CGH data | Q31142505 | ||
| Tumorigenic WAP-T Mouse Mammary Carcinoma Cells: A Model for a Self-Reproducing Homeostatic Cancer Cell System | Q33668830 | ||
| Pro-proliferative FoxM1 is a target of p53-mediated repression | Q33966216 | ||
| Tissue geometry determines sites of mammary branching morphogenesis in organotypic cultures | Q34103254 | ||
| Gain of MYC underlies recurrent trisomy of the MYC chromosome in acute promyelocytic leukemia | Q34340593 | ||
| Modelling breast cancer: one size does not fit all. | Q34667643 | ||
| Stage-dependent regulation of mammary ductal branching by heparan sulfate and HGF-cMet signaling. | Q35056355 | ||
| Common fragile sites are conserved features of human and mouse chromosomes and relate to large active genes | Q35056705 | ||
| Amplification of the neu/erbB-2 oncogene in a mouse model of mammary tumorigenesis. | Q35112126 | ||
| Wild-type p53 controls cell motility and invasion by dual regulation of MET expression | Q35180856 | ||
| Oncogenic PIK3CA-driven mammary tumors frequently recur via PI3K pathway-dependent and PI3K pathway-independent mechanisms | Q35204583 | ||
| Identification of conserved gene expression features between murine mammary carcinoma models and human breast tumors | Q35906418 | ||
| Transforming growth factor-beta employs HMGA2 to elicit epithelial-mesenchymal transition. | Q36118227 | ||
| ETV6-NTRK3 fusion oncogene initiates breast cancer from committed mammary progenitors via activation of AP1 complex | Q36328085 | ||
| Lunatic fringe deficiency cooperates with the Met/Caveolin gene amplicon to induce basal-like breast cancer. | Q36702175 | ||
| Connexins and gap junctions in mammary gland development and breast cancer progression | Q36895379 | ||
| Strain-specific differences in the mechanisms of progesterone regulation of murine mammary gland development | Q37125950 | ||
| FISH and immunohistochemical status of the hepatocyte growth factor receptor (c-Met) in 184 invasive breast tumors | Q37208761 | ||
| The relevance of mouse models to understanding the development and progression of human breast cancer | Q37243959 | ||
| PTEN deficiency in a luminal ErbB-2 mouse model results in dramatic acceleration of mammary tumorigenesis and metastasis | Q37254063 | ||
| Met induces diverse mammary carcinomas in mice and is associated with human basal breast cancer. | Q37293205 | ||
| Met induces mammary tumors with diverse histologies and is associated with poor outcome and human basal breast cancer | Q37293236 | ||
| SV40: Cell transformation and tumorigenesis | Q37345587 | ||
| Transcription-associated recombination in eukaryotes: link between transcription, replication and recombination | Q37367099 | ||
| MET signalling: principles and functions in development, organ regeneration and cancer | Q37811895 | ||
| Replication stress induces sister-chromatid bridging at fragile site loci in mitosis. | Q39847635 | ||
| Redox mechanisms switch on hypoxia-dependent epithelial-mesenchymal transition in cancer cells | Q39939949 | ||
| Frequent met oncogene amplification in a Brca1/Trp53 mouse model of mammary tumorigenesis | Q40296507 | ||
| Gene expression profiling: cell cycle deregulation and aneuploidy do not cause breast cancer formation in WAP-SVT/t transgenic animals. | Q40468145 | ||
| Met signaling regulates growth, repopulating potential and basal cell-fate commitment of mammary luminal progenitors: implications for basal-like breast cancer. | Q42505884 | ||
| Mutant p53(R270H) gain of function phenotype in a mouse model for oncogene-induced mammary carcinogenesis | Q43794889 | ||
| A census of amplified and overexpressed human cancer genes | Q44951771 | ||
| Identification of an integrated SV40 T/t-antigen cancer signature in aggressive human breast, prostate, and lung carcinomas with poor prognosis. | Q50666708 | ||
| The SV40 small t-antigen prevents mammary gland differentiation and induces breast cancer formation in transgenic mice; truncated large T-antigen molecules harboring the intact p53 and pRb binding region do not have this effect. | Q52963884 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1300-1310 | |
| P577 | publication date | 2012-09-26 | |
| P1433 | published in | International Journal of Cancer | Q332492 |
| P1476 | title | Low-grade and high-grade mammary carcinomas in WAP-T transgenic mice are independent entities distinguished by Met expression | |
| P478 | volume | 132 |
| Q33809166 | Aberrant Proliferation of Differentiating Alveolar Cells Induces Hyperplasia in Resting Mammary Glands of SV40-TAg Transgenic Mice |
| Q36629345 | An inducible transgenic mouse breast cancer model for the analysis of tumor antigen specific CD8+ T-cell responses |
| Q37665460 | CEACAM1 controls the EMT switch in murine mammary carcinoma in vitro and in vivo |
| Q40027037 | Cancer immunotherapy: weak beats strong |
| Q38934976 | Chemotherapy of WAP-T mouse mammary carcinomas aggravates tumor phenotype and enhances tumor cell dissemination |
| Q35238838 | Epithelial-mesenchymal plasticity is a decisive feature for the metastatic outgrowth of disseminated WAP-T mouse mammary carcinoma cells |
| Q41924363 | Immunotherapy of WAP-TNP mice with early stage mammary gland tumors |
| Q38959098 | Mutant p53 promotes epithelial-mesenchymal plasticity and enhances metastasis in mammary carcinomas of WAP-T mice |
| Q37662081 | T-cell epitope strength in WAP-T mouse mammary carcinomas is an important determinant in PD1/PD-L1 immune checkpoint blockade therapy. |
| Q39242906 | Transcription factors link mouse WAP-T mammary tumors with human breast cancer |
| Q41404014 | Whole-exome DNA sequence analysis of Brca2- and Trp53-deficient mouse mammary gland tumours |
Search more.